Adimab is the leading provider of therapeutic antibody discovery and engineering technologies. This includes naïve discovery from synthetic libraries in yeast or B cells (mice and humans), antibody engineering and optimization, multi-specific antibody engineering, and a portfolio of proprietary CD3 antibodies licensed non-exclusively for bispecific applications. Adimab focuses solely on its partners and not on developing an internal product pipeline. Since 2009, Adimab has partnered with over 80 pharmaceutical and biotechnology companies, generating more than 360 therapeutic programs, over 40 clinical programs, and its first approved product.

Argo Research strives to maintain an up-to-date database on small medical technology companies, the birthplaces of some of the most radical innovation shaping future clinical practice and outcomes. This information is available on a consulting basis, and is most valuable to those looking for partners or acquisition targets in a particular niche of our industry. 

For more information, visit www.argoresearch.com.

Avitide develops affinity purification manufacturing technologies for the biopharmaceutical industry. From target to affinity purification, Avitide’s 3-month discovery service and proprietary affinity ligand technology platform offers unparalleled speed, performance, and product resolution that enable bioprocess professionals to accelerate clinical development timelines, reduce cost of production, and quickly define a high-capacity and high-purity affinity purification solution for any biopharmaceutical.

For more information, visit www.avitide.com.

CairnSurgical LLC designs and manufactures surgical and medical instruments.

Website coming soon.

Celdara builds academic and early-stage inventions into high-potential medical companies. CM identifies discoveries and inventions of exceptional value at the earliest stages, engages the inventor and their institution to access the technology, and builds a business around the technology within CM. When successful, we may spin the business out as part of an A-round of financing, or grow it organically into either a source of cash flow or a trade sale target.

For more information, visit www.celdaramedical.com.

Pharma companies view current methods of respiratory monitoring as inconsistent, burdensome, and constrained to a single point in time. Clairways solves these problems with our small wearable lung function monitor. We provide reliable, burden-free, long-term monitoring of all of the most important respiratory metrics, including the single most relied upon measure of lung function, FEV1, and several key symptoms, such as coughing and wheezing.

DoseOptics LLC is a medical imaging company developing the first clinical visualization techniques for radiation therapy.  Using the same principals which generate the “blue glow” seen in many nuclear reactor photos, DoseOptics has developed a way to precisely image this phenomenon in patients undergoing radiation therapy. The resulting video images capture the actual treatment in real time, on the patient and are used to monitor, verify and record the treatment.  

For more information, please visit www.doseoptics.com.

FirstLight Fiber headquartered in Albany, NY, provides fiber optic data, voice, and high-speed Internet services to enterprise and carrier customers in Upstate NY and Northern NE with connectivity to Canada utilizing its own fiber optic network, which spans over 215,000 fiber miles connecting in excess of 1,600 lit buildings.  FirstLight offers a robust suite of advanced telecommunications products, including dedicated Internet access, Ethernet, Data Center Colocation and voice services. 

For more information, please visit www.firstlight.net.

FreshAir Sensor LLC is focused on improving safety and comfort by detecting environmental contaminants. The initial focus is on cigarette and marijuana smoke. Second and thirdhand smoke are serious health hazards to which many people are unwillingly exposed. FreshAir allows customers to effectively prevent smoking in unobserved areas.

FreshAir uses a novel sensor technology to detect cigarettes and marijuana. The sensor uses Wi-Fi to communicate with the FreshAir online platform. When cigarettes or marijuana are detected the customer will be immediately notified by e-mail. When the event is over the customer will receive a chart showing the measurement of the substance detected.

While FreshAir provides clear proof that smoking has taken place in a prohibited area, it also provides an effective deterrent to smoking. With FreshAir it is possible to immediately address the situation if someone is smoking in a prohibited area.

For more information, visit www.freshairsensor.com.

At Javelin Oncology our core mission is create safe cures for solid tumors. In doing so, we intend to build the leading company in the new paradigm of precision medicine.

myTurn.com, pbc offers a software platform that helps organizations track, rent, and share tools equipment or any resource. 

Businesses use our platform to track and maximize equipment usage internally and generate revenue by renting out underutilized equipment to other businesses or individuals. Universities use myTurn to manage bike lending and equipment sharing programs on campus. In cities, myTurn is used to create “Libraries of Things” where people can access power tools, sporting goods, kitchen equipment, and other products by paying a subscription fee rather than needing to purchase, maintain and eventually dispose of products themselves. Items on the myTurn platform often see 10 to 100 times the utilization compared to individual ownership.

Learn more at:myTurn.com

At Pete & Gerry’s Organic Eggs, our family has been farming for four generations. We are totally committed to bringing you the highest-quality, freshest eggs possible.

PreventAGE Health Care was founded with the goal of fundamentally improving diabetes care by providing patients and doctors with the necessary tools to predict and more effectively manage diabetic complications. As the number of diabetics, the number of pre-diabetics, and the staggering costs to manage the disease continue to rise, there is an urgent need to better identify populations at risk for developing complications. With a window into a patient’s future, it will be possible to delay, stop or reverse problems with targeted, cost-effective treatments in a timeframe that would make a difference.                                                                

Built on over two decades of complications-focused research, our unique technologies can provide individual risk profiles and also stimulate development of therapeutic approaches to delay or arrest complications.

For more information visit us at www.preventagehealthcare.com.

Ryan Halter is founder of RyTek Medical, a small, fairly new organization in the surgical and medical instrument space. Description and website coming soon.

VivCyte is developing Serum-free solution for cell culture and cyropreservation of lymphocytes, stem cells.  Website coming soon.

Specializing in single-chip network security solutions leveraging System-On-Chip (SoC) and Field Programmable Gate Array (FPGA) Architectures through High-Level Synthesis (HLS)